je.st
news
Moberg Pharma: Patient Enrollment Completed in Clinical Study of MOB-015
2013-05-27 09:16:06| Appliances - Topix.net
Moberg Pharma AB today announced the completion of patient enrollment in the ongoing Phase II clinical trial of MOB-015. MOB-015 is a topical formulation of terbinafine for the treatment of nail fungus .
Tags: study
completed
patient
clinical
Category:Consumer Goods and Services